Phenotypic Spectrum of Heart Failure with Preserved Ejection Fraction

Heart Failure Clinics

Volumn 10, Issue 3, 2014, Pages 407-418

  Shah, Sanjiv J ^a   Katz, Daniel H ^a   Deo, Rahul C ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Classification; Clinical trials; Etiology; Heart failure with preserved ejection fraction; Pathophysiology; Phenomics; Phenotype

Indexed keywords

AORTA VALVE REGURGITATION; CLINICAL CLASSIFICATION; COLOR ULTRASOUND FLOWMETRY; DISEASE CLASSIFICATION; GENE EXPRESSION; GENE MAPPING; GENOMICS; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERVOLEMIA; MITRAL VALVE REGURGITATION; PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; REVIEW; SYSTEMATIC REVIEW; TRICUSPID VALVE REGURGITATION; AGED; CLINICAL TRIAL (TOPIC); DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; EPIDEMIOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEART FAILURE; HEART STROKE VOLUME; MALE; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; SYNDROME; TREATMENT OUTCOME; VERY ELDERLY;

CARDIOTONIC AGENT;

AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; CLINICAL TRIALS AS TOPIC; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PHENOTYPE; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; STROKE VOLUME; SYNDROME; TREATMENT OUTCOME;

EID: 84903435949     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2014.04.008     Document Type: Review

References (48)

1. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2013, 62(16):e147-e239.
2. Oktay A.A., Shah S.J. Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessons. Curr Cardiol Rev 2013, [Epub ahead of print].
3. Oktay A.A., Rich J.D., Shah S.J. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep 2013, 10(4):401-410.
4. Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127(1):e6-e245.
5. Shah A.M., Pfeffer M.A. The many faces of heart failure with preserved ejection fraction. Nat Rev Cardiol 2012, 9(10):555-556.
6. Shah A.M., Solomon S.D. Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction. Eur Heart J 2012, 33(14):1716-1717.
7. Shah S.J. Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter. JAm Coll Cardiol 2013, 62(15):1339-1342.
8. Borlaug B.A., Paulus W.J. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011, 32(6):670-679.
9. Borlaug B.A., Redfield M.M. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 2011, 123(18):2006-2013. [discussion: 2014].
10. Yancy C.W., Lopatin M., Stevenson L.W., et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. JAm Coll Cardiol 2006, 47(1):76-84.
11. Bursi F., Weston S.A., Redfield M.M., et al. Systolic and diastolic heart failure in the community. JAMA 2006, 296(18):2209-2216.
12. Prasad A., Hastings J.L., Shibata S., et al. Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction. Circ Heart Fail 2010, 3(5):617-626.
13. Maurer M.S., King D.L., El-Khoury Rumbarger L., et al. Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. JCard Fail 2005, 11(3):177-187.
14. Kliger C., King D.L., Maurer M.S. Aclinical algorithm to differentiate heart failure with a normal ejection fraction by pathophysiologic mechanism. Am J Geriatr Cardiol 2006, 15(1):50-57.
15. Bench T., Burkhoff D., O'Connell J.B., et al. Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction. Curr Heart Fail Rep 2009, 6(1):57-64.
16. Burkhoff D., Maurer M.S., Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?. Circulation 2003, 107(5):656-658.
17. Ather S., Chan W., Bozkurt B., et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. JAm Coll Cardiol 2012, 59(11):998-1005.
18. Edelmann F., Stahrenberg R., Gelbrich G., et al. Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol 2011, 100(9):755-764.
19. Mohammed S.F., Borlaug B.A., Roger V.L., et al. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 2012, 5(6):710-719.
20. Paulus W.J., Tschope C. Anovel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. JAm Coll Cardiol 2013, 62(4):263-271.
21. Shah S.J., Gheorghiade M. Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA 2008, 300(4):431-433.
22. Aurigemma G.P., Gaasch W.H. Clinical practice. Diastolic heart failure. NEngl J Med 2004, 351(11):1097-1105.
23. Burke M.A., Katz D.H., Beussink L., et al. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2014, 7(2):288-299.
24. Zile M.R., Baicu C.F., Gaasch W.H. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. NEngl J Med 2004, 350(19):1953-1959.
25. Shah S.J. Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease. Curr Treat Options Cardiovasc Med 2010, 12(1):58-75.
26. Liu Y.W., Tsai W.C., Su C.T., et al. Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. JCard Fail 2009, 15(9):782-789.
27. Kawaguchi M., Hay I., Fetics B., et al. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107(5):714-720.
28. Borlaug B.A., Melenovsky V., Russell S.D., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114(20):2138-2147.
29. Thenappan T., Shah S.J., Gomberg-Maitland M., et al. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2011, 4(3):257-265.
30. Lam C.S., Roger V.L., Rodeheffer R.J., et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. JAm Coll Cardiol 2009, 53(13):1119-1126.
31. Phan T.T., Shivu G.N., Abozguia K., et al. Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3(1):29-34.
32. Shah S.J. Pulmonary hypertension. JAMA 2012, 308(13):1366-1374.
33. Borlaug B.A., Nishimura R.A., Sorajja P., et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3(5):588-595.
34. Maeder M.T., Thompson B.R., Htun N., et al. Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fraction. JCard Fail 2012, 18(9):702-710.
35. Burgess M.I., Jenkins C., Sharman J.E., et al. Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. JAm Coll Cardiol 2006, 47(9):1891-1900.
36. Ha J.W., Oh J.K., Pellikka P.A., et al. Diastolic stress echocardiography: a novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise Doppler echocardiography. JAm Soc Echocardiogr 2005, 18(1):63-68.
37. Kane G.C., Oh J.K. Diastolic stress test for the evaluation of exertional dyspnea. Curr Cardiol Rep 2012, 14(3):359-365.
38. Anjan V.Y., Loftus T.M., Burke M.A., et al. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic Peptide levels in heart failure with preserved ejection fraction. Am J Cardiol 2012, 110(6):870-876.
39. Shah S.J., Heitner J.F., Sweitzer N.K., et al. Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial. Circ Heart Fail 2013, 6(2):184-192.
40. Gerges C., Gerges M., Lang M.B., et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest 2013, 143(3):758-766.
41. Tracy R.P. 'Deep phenotyping': characterizing populations in the era of genomics and systems biology. Curr Opin Lipidol 2008, 19(2):151-157.
42. Ballman K.V. Genetics and genomics: gene expression microarrays. Circulation 2008, 118(15):1593-1597.
43. Eisen M.B., Spellman P.T., Brown P.O., et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95(25):14863-14868.
44. Lemon S.C., Roy J., Clark M.A., et al. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 2003, 26(3):172-181.
45. Shah S.J., Wasserstrom J.A. SERCA2a gene therapy for the prevention of sudden cardiac death: a future theranostic for heart failure?. Circulation 2012, 126(17):2047-2050.
46. Fraley C., Raftery A.E. Model-based clustering, discriminant analysis, and density estimation. JAm Stat Assoc 2002, 97:611-631.
47. Hastie T., Tibshirani R., Friedman J. Unsupervised learning: hierarchical clustering. The elements of statistical learning 2009, 520-528. Springer, New York. 2nd edition. T. Hastie, R. Tibshirani, J. Friedman (Eds.).
48. Friedman J., Hastie T., Tibshirani R. Regularization paths for generalized linear models via coordinate descent. JStat Softw 2010, 33(1):1-22.